Biomea Fusion’s experimental drug, BMF-500, is showing promising early results in its ongoing Phase 1 COVALENT-103 clinical trial. This drug is being tested as a treatment for relapsed or ...

logos, font, technology, and powertrains—for a future without internal-combustion engines. By the end of 2025, the petrol-powered lineup will be dead. “Until now, I don’t think there have ...